2004
DOI: 10.1074/jbc.m303855200
|View full text |Cite
|
Sign up to set email alerts
|

Rat Brain Cortex Mitochondria Release Group II Secretory Phospholipase A2 under Reduced Membrane Potential

Abstract: Activation of brain mitochondrial phospholipase(s) A 2 (PLA 2 ) might contribute to cell damage and be involved in neurodegeneration. Despite the potential importance of the phenomenon, the number, identities, and properties of these enzymes are still unknown. Here, we demonstrate that isolated mitochondria from rat brain cortex, incubated in the absence of respiratory substrates, release a Ca 2؉ -dependent PLA 2 having biochemical properties characteristic to secreted PLA 2 (sPLA 2 ) and immunoreacting with t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
33
0

Year Published

2006
2006
2010
2010

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(37 citation statements)
references
References 90 publications
4
33
0
Order By: Relevance
“…The finding is consistent with previous studies which showed the enzyme in mitochondria of myocardial cells [46] and rabbit proximal tubular cells [47]. Besides iPLA 2 , other PLA 2 isoforms such as cPLA 2 , and sPLA 2 -IIA, -III, -V and -X have been localized in PC12 cells [48][49][50][51][52][53]. sPLA 2 -IIA is present in mitochondria, whilst sPLA 2 -V showed mainly nuclear localization in these cells [49].…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…The finding is consistent with previous studies which showed the enzyme in mitochondria of myocardial cells [46] and rabbit proximal tubular cells [47]. Besides iPLA 2 , other PLA 2 isoforms such as cPLA 2 , and sPLA 2 -IIA, -III, -V and -X have been localized in PC12 cells [48][49][50][51][52][53]. sPLA 2 -IIA is present in mitochondria, whilst sPLA 2 -V showed mainly nuclear localization in these cells [49].…”
Section: Discussionsupporting
confidence: 92%
“…Besides iPLA 2 , other PLA 2 isoforms such as cPLA 2 , and sPLA 2 -IIA, -III, -V and -X have been localized in PC12 cells [48][49][50][51][52][53]. sPLA 2 -IIA is present in mitochondria, whilst sPLA 2 -V showed mainly nuclear localization in these cells [49]. Treatment of PC12 cells with BEL resulted in reduction of mitochondrial membrane potential, similar to that observed after treatment with the mitochondrial depolarizing agent FCCP.…”
Section: Discussionsupporting
confidence: 55%
“…However, it is proposed that at the molecular level, heparan sulfate, a glycosaminoglycan, may play an important role in internalization and attachment of PLA 2 isoforms to intracellular organelles Boilard et al, 2003). A reduction in the mitochondrial membrane potential causes the release of sPLA 2 and this sPLA 2 along with other PLA 2 isoforms may be involved in neural cell injury (Farooqui et al, 1997d;Macchioni et al, 2004).…”
Section: A Secretory Phospholipase Amentioning
confidence: 99%
“…In brain, Data summarized from Hirashima et al (1992); Matsuzawa et al (1996); Yang et al (1999);and Farooqui et al (2000b EFFECTS OF PLA 2 INHIBITORS 593 astrocytes express sPLA 2 , which can be induced in response to proinflammatory cytokines such as tumor necrosis factor-␣ and interleukin-1␤ (Lin et al, 2004). Mitochondrial fractions from rat brain, PC12, and U251 astrocytoma cell cultures contain significant sPLA 2 and iPLA 2 activities (Macchioni et al, 2004). The mechanism for a secretory protein (like sPLA 2 ) targeting an intracellular organelle (like mitochondria) remains unknown.…”
Section: A Secretory Phospholipase Amentioning
confidence: 99%
“…GIIA, which is ubiquitously expressed in all areas of mammalian brain [16] and accounts for most of the PLA 2 activity detected in particulate fractions of rat brain [17]. In PC12 cells and in other neural cell lines GIIA has a cytosolic and mitochondrial localization [18]. Several lines of evidence indicate the involvement of this isoform in the onset and/or aggravation of various neurological diseases (for review see [13]).…”
Section: Introductionmentioning
confidence: 98%